Erratum to “Biparametric 3t magnetic resonance imaging for prostatic cancer detection in a biopsy-naïve patient population: A further improvement of PI-RADS v2? [Eur. J. Radiol. (2016) 85(12) (2269–2274)](S0720048X16303072)(10.1016/j.ejrad.2016.10.009);Biparametric 3T Magentic Resonance Imaging for prostatic cancer detection in a biopsy-naïve patient population: a further improvement of PI-RADS v2?

European Journal of Radiology

Volumn 85, Issue 12, 2016, Pages 2269-2274

  Stanzione, Arnaldo ^a   Imbriaco, Massimo ^a   Cocozza, Sirio ^a   Fusco, Ferdinando ^a   Rusconi, Giovanni ^a   Nappi, Carmela ^a   Mirone, Vincenzo ^a   Mangiapia, Francesco ^a   Brunetti, Arturo ^a   Ragozzino, Alfonso ^b   Longo, Nicola ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Ospedale S Maria delle Grazie   (Italy)

Author keywords

Medical oncology; MRI; PI RADS; Prostate cancer; Urologic diseases

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE; PROSTATE SPECIFIC ANTIGEN; CONTRAST MEDIUM;

ADULT; AGED; APPARENT DIFFUSION COEFFICIENT; ARTICLE; BIPARAMETRIC 3T MAGNETIC RESONANCE IMAGING; CANCER DIAGNOSIS; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING; GLEASON SCORE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; RADIOLOGIST; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; T2 WEIGHTED IMAGING; AREA UNDER THE CURVE; CANCER GRADING; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; FEASIBILITY STUDY; IMAGE ENHANCEMENT; IMAGE GUIDED BIOPSY; IMAGE PROCESSING; INTERVENTIONAL ULTRASONOGRAPHY; MIDDLE AGED; PROCEDURES; PROSTATE TUMOR; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEASIBILITY STUDIES; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGE-GUIDED BIOPSY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; ROC CURVE; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84994728966     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2016.12.011     Document Type: Erratum

References (28)

1. [1] American Cancer Society, Cancer Facts & Figures. 2014, American Cancer Society.
2. [2] McNeal, J.E., Redwine, E.A., Freiha, F.S., Stamey, T.A., Zonal distribution of prostatic adenocarcinoma: correlation with histologic pattern and direction of spread. Am. J. Surg. Pathol. 12:12 (1988), 897–906.
3. [3] Djavan, B., Ravery, V., Zlotta, A., et al. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?. J. Urol. 166:5 (2001), 1679–1683.
4. [4] Roehl, K.A., Antenor, J.A., Catalona, W.J., Serial biopsy results in prostate cancer screening study. J. Urol. 167:6 (2002), 2435–2439.
5. [5] Scattoni, V., Zlotta, A., Montironi, R., Schulman, C., Rigatti, P., Montorsi, F., Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature. Eur. Urol. 52:5 (2007), 1309–1322.
6. [6] Abd-Alazeez, M., Ahmed, H.U., Arya, M., et al. The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level-can it rule out clinically significant prostate cancer?. Urol. Oncol. 32:1 (2014), e17–e22 45.
7. [7] Pinto, P.A., Chung, P.H., Rastinehad, A.R., et al. Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. J. Urol. 186:4 (2011), 1281–1285.
8. [8] Rastinehad, A.R., Baccala, A.A. Jr., Chung, P.H., et al. D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging. J. Urol. 185:3 (2011), 815–820.
9. [9] Stamatakis, L., Siddiqui, M.M., Nix, J.W., et al. Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer. Cancer 119:18 (2013), 3359–3366.
10. [10] Turkbey, B., Mani, H., Shah, V., et al. Multiparametric 3 T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. J. Urol. 186:5 (2011), 1818–1824.
11. [11] Vourganti, S., Rastinehad, A., Yerram, N.K., et al. Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies. J. Urol. 188:6 (2012), 2152–2157.
12. [12] Barentsz, J.O., Richenberg, J., Clements, R., et al. ESUR prostate MR guidelines 2012. Eur. Radiol. 22:4 (2012), 746–757.
13. [13] Hamoen, E.H., de Rooij, M., Witjes, J.A., Barentsz, J.O., Rovers, M.M., Use of the prostate imaging reporting and data system (PI-RADS) for prostate cancer detection with multiparametric magnetic resonance imaging: a diagnostic meta-analysis. Eur. Urol. 67:6 (2015), 1112–1121.
14. [14] Renard-Penna, R., Mozer, P., Cornud, F., et al. Prostate imaging reporting and data system and likert scoring system: multiparametric MR imaging validation study to screen patients for initial biopsy. Radiology 275:2 (2015), 458–468.
15. [15] Weinreb, J.C., Barentsz, J.O., Choyke, P.L., et al. PI-RADS prostate imaging—reporting and data system: 2015, version 2. Eur. Urol. 69:1 (2016), 16–40.
16. [16] Scialpi, M., Falcone, G., Scialpi, P., D'Andrea, A., Biparametric, M.R.I., a further improvement to PIRADS 2.0?. Diagn. Interv. Radiol. 22:3 (2016), 297–298.
17. [17] Fascelli, M., Rais-Bahrami, S., Sankineni, S., et al. Combined biparametric prostate magnetic resonance imaging and prostate-specific antigen in the detection of prostate cancer: a validation study in a biopsy-naive patient population. Urology 88 (2016), 125–134.
18. [18] Rais-Bahrami, S., Siddiqui, M.M., Vourganti, S., et al. Diagnostic value of biparametric magnetic resonance imaging (MRI) as an adjunct to prostate-specific antigen (PSA)-based detection of prostate cancer in men without prior biopsies. BJU Int. 115:3 (2015), 381–388.
19. [19] Mottet, N., Bellmunt, J., Bolla, M., et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening diagnosis, and local treatment with curative intent. Eur. Urol., 2016, 2016.
20. [20] DeLong, E.R., DeLong, D.M., Clarke-Pearson, D.L., Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:3 (1988), 837–845.
21. [21] Akin, O., Sala, E., Moskowitz, C.S., et al. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology 239:3 (2006), 784–792.
22. [22] Turkbey, B., Mani, H., Aras, O., et al. Correlation of magnetic resonance imaging tumor volume with histopathology. J. Urol. 188:4 (2012), 1157–1163.
23. [23] Turkbey, B., Pinto, P.A., Mani, H., et al. Prostate cancer: value of multiparametric MR imaging at 3 T for detection–histopathologic correlation. Radiology 255:1 (2010), 89–99.
24. [24] Hegde, J.V., Mulkern, R.V., Panych, L.P., et al. Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer. J. Magn. Reson. Imaging 37:35 (2013), 1035–1054.
25. [25] Stojanov, D., Aracki-Trenkic, A., Benedeto-Stojanov, D., Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents-current status. Neuroradiology 58:5 (2016), 433–441.
26. [26] Tedeschi, E., Palma, G., Canna, A., et al. In vivo dentate nucleus MRI relaxometry correlates with previous administration of Gadolinium-based contrast agents. Eur. Radiol., 2016.
27. [27] Hoang Dinh, A., Melodelima, C., Souchon, R., et al. Quantitative analysis of prostate multiparametric MR images for detection of aggressive prostate cancer in the peripheral zone: a multiple imager study. Radiology 280:1 (2016), 117–127.
28. [28] Park, S.Y., Jung, D.C., Oh, Y.T., et al. Prostate cancer: PI-RADS version 2 helps preoperatively predict clinically significant cancers. Radiology 280:1 (2016), 108–116.